Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

BSX

Boston Scientific Corp.

Sep 20 • 04:00PM ET

83.92

Dollar change +0.21
Percentage change 0.25	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO SPY IVV VUG XLV VHT IWD IHI JEPI

Index	S&P 500	P/E	67.90	EPS (ttm)	1.24	Insider Own	0.43%	Shs Outstand	1.47B	Perf Week	0.73%
Market Cap	123.58B	Forward P/E	30.70	EPS next Y	2.73	Insider Trans	-7.54%	Shs Float	1.47B	Perf Month	6.48%
Income	1.83B	PEG	5.29	EPS next Q	0.59	Inst Own	91.63%	Short Float	0.75%	Perf Quarter	7.99%
Sales	15.23B	P/S	8.12	EPS this Y	17.48%	Inst Trans	0.92%	Short Ratio	1.96	Perf Half Y	24.22%
Book/sh	13.85	P/B	6.06	EPS next Y	13.49%	ROA	5.16%	Short Interest	11.02M	Perf Year	55.12%
Cash/sh	2.03	P/C	41.36	EPS next 5Y	12.84%	ROE	9.46%	52W Range	48.35 - 84.89	Perf YTD	45.17%
Dividend Est.	-	P/FCF	67.13	EPS past 5Y	-2.05%	ROI	6.15%	52W High	-1.14%	Beta	0.80
Dividend TTM	-	Quick Ratio	1.14	Sales past 5Y	8.10%	Gross Margin	62.04%	52W Low	73.57%	ATR (14)	1.36
Dividend Ex-Date	-	Current Ratio	1.61	EPS Y/Y TTM	108.08%	Oper. Margin	16.46%	RSI (14)	67.85	Volatility	1.73% 1.52%
Employees	48000	Debt/Eq	0.54	Sales Y/Y TTM	13.64%	Profit Margin	12.00%	Recom	1.46	Target Price	88.28
Option/Short	Yes / Yes	LT Debt/Eq	0.46	EPS Q/Q	21.82%	Payout	0.00%	Rel Volume	1.24	Prev Close	83.71
Sales Surprise	2.26%	EPS Surprise	6.27%	Sales Q/Q	14.48%	Earnings	Jul 24 BMO	Avg Volume	5.63M	Price	83.92
SMA20	2.70%	SMA50	6.91%	SMA200	19.45%	Trades		Volume	6,966,878	Change	0.25%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51
Apr-15-21	Initiated	Atlantic Equities	Overweight	$52
Sep-17-20	Initiated	Truist	Buy	$47
Sep-11-20	Initiated	Wolfe Research	Peer Perform	$46

Show Previous Ratings

Today 12:45PM	Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
12:00PM	Boston Scientific (BSX) Is Up 2.10% in One Week: What You Should Know (Zacks)
11:54AM	Medtronics Aurora EV-ICD to challenge Boston Scientifics S-ICD market leadership (Medical Device Network)
09:30AM	Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? (Zacks)
09:15AM	Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out? (Zacks)
08:02AM	Loading…
Sep-19-24 08:02AM	Jury sides with Axonics in Medtronic patent dispute (MedTech Dive)
Sep-18-24 09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
Sep-17-24 06:00PM	Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
12:34PM	Boston Scientific expands FDA label for Ingevity+ pacing leads (Medical Device Network)
08:31AM	Boston Scientific Closes Acquisition of Silk Road Medical, Inc. (PR Newswire)
07:00AM	Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area (PR Newswire)
Sep-16-24 08:03PM	Boston Scientific Corporation (BSX): Among Morgan Stanley's Best Stock Picks for 2025 (Insider Monkey)
Sep-13-24 08:10AM	Boston Scientific, Silk Road expect to close merger in coming days (MedTech Dive)
Sep-11-24 06:00PM	Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts (Zacks)
Sep-05-24 06:00PM	Boston Scientific (BSX) Dips More Than Broader Market: What You Should Know (Zacks)
08:32AM	Loading…
08:32AM	15 Healthiest Countries in Europe (Insider Monkey)
Sep-03-24 12:57PM	Boston Scientific Shares Rising Higher (FX Empire)
Aug-30-24 06:00PM	Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider (Zacks)
Aug-28-24 06:00AM	Boston Scientific receives CE mark for updated TAVR technology (MedTech Dive)
Aug-27-24 11:13AM	Boston Scientific receives CE mark for ACURATE Prime TAVR system (Medical Device Network)
06:57AM	Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System (PR Newswire)
Aug-23-24 11:30AM	Why Is Boston Scientific (BSX) Up 7.2% Since Last Earnings Report? (Zacks)
Aug-22-24 12:45PM	Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Aug-21-24 09:40AM	Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-20-24 10:05PM	Is Boston Scientific Corporation (BSX) The Best Blue Chip Stock Under $100? (Insider Monkey)
11:56AM	Boston Scientific (BSX), Silk Road Merger Delayed for Review (Zacks)
Aug-18-24 02:06PM	10 Best Blue Chip Stocks Under $100 (Insider Monkey)
Aug-16-24 08:14AM	Boston Scientific resubmits Silk Road merger filing, giving FTC more review time (MedTech Dive)
Aug-13-24 08:00AM	Boston Scientific to Participate in Wells Fargo's 2024 Healthcare Conference (PR Newswire)
03:32AM	Transvaginal mesh timeline: the gynaecological scandal that rocked the world (Medical Device Network)
09:30AM	Loading…
Aug-09-24 09:30AM	Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? (Zacks)
Aug-06-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX) (Zacks)
Aug-02-24 06:00AM	Hypergrowth Heroes: 7 Stocks That Could 10X Your Money (InvestorPlace)
05:54AM	What Makes Boston Scientific Corporation (BSX) a Compelling Investment? (Insider Monkey)
Aug-01-24 08:36AM	Are Options Traders Betting on a Big Move in Boston Scientific (BSX) Stock? (Zacks)
Jul-31-24 12:30PM	Boston Scientific (BSX) Rides on Global Growth, Buyouts (Zacks)
09:50AM	How Boston Scientifics digital and IT boss upgraded her team from order takers to strategic thinkers (Fortune)
Jul-30-24 04:05PM	Boston Scientific Elects David Habiger to Board of Directors (PR Newswire)
Jul-26-24 10:30AM	Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review (Investor's Business Daily)
Jul-25-24 12:30PM	S&P 500s Biggest Loser Has a Heart Valve Problem (The Wall Street Journal)
02:58AM	Q2 2024 Boston Scientific Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-24-24 04:44PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
04:08PM	Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat (Investor's Business Daily)
12:53PM	Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular Devices Leads To 2024 Guidance Hike Again (Benzinga)
12:48PM	Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise (Zacks)
12:11PM	Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand (Investopedia)
10:07AM	Boston Sci Slumps After A Key Segment Grows 70%, But Misses Loftier Forecasts (Investor's Business Daily)
09:30AM	Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:58AM	Boston Scientific Earnings Beat; Medtech Giant Raises Guidance (Investor's Business Daily)
07:40AM	Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:13AM	Midday movers: Tesla, Alphabet, Visa fall; AT&T, Texas Instruments rise (Investing.com)
06:37AM	Boston Scientific: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Boston Scientific Announces Results for Second Quarter 2024 (PR Newswire)
03:34AM	Boston Scientific Corporation (BSX) is Benefitting From Several Factors (Insider Monkey)
Jul-22-24 11:38AM	Boston Scientific (BSX) Banks on Global Expansion, Innovation (Zacks)
05:32AM	PFA disrupts electrophysiology ablation catheters market (Medical Device Network)
Jul-20-24 08:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-17-24 10:01AM	Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
Jul-16-24 11:23AM	Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? (Zacks)
Jul-15-24 06:00PM	Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider (Zacks)
Jul-11-24 06:15PM	Boston Scientific (BSX) Stock Moves -0.29%: What You Should Know (Zacks)
Jul-10-24 10:13AM	Energised US market opportunity for pulsed field ablation (Medical Device Network)
Jul-03-24 10:45AM	Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline (Insider Monkey)
10:23AM	Here's Why Artisan Global Discovery Fund Trimmed Veeva Systems (VEEV) (Insider Monkey)
Jul-02-24 10:00AM	There Are Better Options Than Boston Scientific (GuruFocus.com)
Jul-01-24 08:00AM	Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results (PR Newswire)
Jun-28-24 06:00PM	Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note (Zacks)
Jun-26-24 02:11PM	7 Biotech Stocks to Boost Your Portfolio to Peak Health (InvestorPlace)
11:22AM	Boston Scientifics DBS software gains CE as Parkinsons treatments advance (Medical Device Network)
09:55AM	Boston Scientific (BSX) DBS Programming Software Gets CE Mark (Zacks)
Jun-25-24 07:14AM	3 Record-Breaking Stocks With More Room to Run (InvestorPlace)
Jun-24-24 06:15PM	Why Boston Scientific (BSX) Dipped More Than Broader Market Today (Zacks)
09:45AM	Is Boston Scientific Corporation (BSX) a Good Healthcare Stock to Buy (Insider Monkey)
09:13AM	10 Best Healthcare Stocks to Buy According to Hedge Funds (Insider Monkey)
07:53AM	Boston Scientific secures CE mark for Deep Brain Stimulation software (Medical Device Network)
Jun-21-24 09:00AM	The Power of Finding the Sweet Spot of Hybrid Work (The Wall Street Journal)
09:00AM	The Case for Hybrid Work: More Innovation and Greater Employee Engagement (The Wall Street Journal)
Jun-19-24 09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
08:48AM	Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology (Zacks)
Jun-18-24 06:00PM	Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
04:21PM	Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover (Investor's Business Daily)
12:26PM	Top Stock Movers Now: Lennar, NextEra Energy, La-Z-Boy, and More (Investopedia)
11:54AM	Boston Scientific spends $1.26bn to acquire TCAR specialist Silk Road Medical (Medical Device Network)
10:39AM	Boston Scientific Buys Silk Road Medical for $1.26 Billion (Investopedia)
09:38AM	Silk Road Medical Stock Soars. Its Being Acquired by Boston Scientific. (Barrons.com)
09:17AM	Boston Scientific to Buy Silk Road Medical for About $1.26 Billion (The Wall Street Journal)
07:00AM	Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific (GlobeNewswire)
07:00AM	Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc. (PR Newswire)
Jun-17-24 07:10AM	PFA devices are changing AFib treatment. The next wave could grow the market further. (MedTech Dive)
Jun-12-24 10:35PM	REGN, CI, BSX: Which Strong Buy Healthcare Stock Is the Best Bet? (TipRanks)
06:00PM	Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Jun-10-24 06:00AM	Pulsed field ablation to cannibalize radiofrequency, cryo: Needham (MedTech Dive)
Jun-06-24 06:00PM	Boston Scientific (BSX) Gains As Market Dips: What You Should Know (Zacks)
Jun-03-24 06:58AM	Medtech venture capital investing rebounded in Q1 (MedTech Dive)
May-31-24 06:00PM	Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
May-29-24 06:05AM	Artisan Small Cap Fund Exited Axonics (AXNX) on an Acquisition Announcement (Insider Monkey)
May-27-24 07:17AM	Here's Why You Should Buy Boston Scientific (BSX) Stock Now (Zacks)
May-24-24 11:31AM	Boston Scientific (BSX) Up 1.5% Since Last Earnings Report: Can It Continue? (Zacks)
May-23-24 10:05AM	Boston Scientific (BSX) Rides on Emerging Markets, MedSurg (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahoney Michael F	Chairman, President & CEO	Sep 05 '24	Option Exercise	16.79	111,886	1,878,261	1,785,764	Sep 06 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Sep 05 '24	Sale	81.17	162,777	13,212,544	1,622,987	Sep 06 04:12 PM
MICHAEL F MAHONEY	Officer	Sep 05 '24	Proposed Sale	81.17	162,777	13,212,533		Sep 05 04:03 PM
Carruthers Wendy	EVP, Human Resources	Sep 03 '24	Option Exercise	19.31	4,263	82,306	44,451	Sep 03 05:29 PM
Carruthers Wendy	EVP, Human Resources	Sep 03 '24	Sale	81.70	6,983	570,511	37,468	Sep 03 05:29 PM
WENDY CARRUTHERS	Officer	Sep 03 '24	Proposed Sale	81.70	6,983	570,511		Sep 03 04:06 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 28 '24	Sale	80.00	14,132	1,130,560	176,355	Aug 29 04:13 PM
JOSEPH M FITZGERALD	Officer	Aug 28 '24	Proposed Sale	80.00	14,132	1,130,560		Aug 28 04:21 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 26 '24	Option Exercise	21.40	4,185	89,542	24,814	Aug 26 04:32 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 26 '24	Sale	79.25	14,012	1,110,515	10,802	Aug 26 04:32 PM
ARTHUR C BUTCHER	Officer	Aug 26 '24	Proposed Sale	79.25	14,012	1,110,514		Aug 26 04:02 PM
Carruthers Wendy	EVP, Human Resources	Aug 01 '24	Option Exercise	19.31	4,263	82,306	47,171	Aug 01 05:13 PM
Carruthers Wendy	EVP, Human Resources	Aug 01 '24	Sale	74.12	6,983	517,580	40,188	Aug 01 05:13 PM
WENDY CARRUTHERS	Officer	Aug 01 '24	Proposed Sale	74.12	6,983	517,580		Aug 01 04:14 PM
Carruthers Wendy	EVP, Human Resources	Jul 01 '24	Option Exercise	19.31	4,263	82,306	49,891	Jul 02 04:13 PM
Carruthers Wendy	EVP, Human Resources	Jul 01 '24	Sale	77.30	6,983	539,786	42,908	Jul 02 04:13 PM
Carruthers Wendy	EVP, Human Resources	Jun 03 '24	Option Exercise	19.31	4,263	82,306	52,611	Jun 03 05:39 PM
Carruthers Wendy	EVP, Human Resources	Jun 03 '24	Sale	75.33	6,983	526,029	45,628	Jun 03 05:39 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	May 29 '24	Option Exercise	17.26	33,726	582,111	91,824	May 30 04:27 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	May 29 '24	Sale	75.10	63,802	4,791,447	28,022	May 30 04:27 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 28 '24	Option Exercise	21.40	4,186	89,565	34,208	May 29 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 28 '24	Sale	75.34	14,011	1,055,590	20,197	May 29 05:04 PM
Brennan Daniel J.	EVP and CFO	May 22 '24	Option Exercise	21.33	64,454	1,374,836	335,996	May 23 04:12 PM
Brennan Daniel J.	EVP and CFO	May 22 '24	Sale	75.91	64,454	4,892,819	271,542	May 23 04:12 PM
Brennan Daniel J.	EVP and CFO	May 23 '24	Sale	75.11	47,621	3,576,932	223,921	May 23 04:12 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '24	Option Exercise	24.55	18,037	442,808	50,363	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 22 '24	Option Exercise	27.09	15,006	406,513	47,332	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '24	Sale	75.60	18,037	1,363,606	32,326	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 22 '24	Sale	76.01	15,006	1,140,633	32,326	May 23 04:11 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 10 '24	Option Exercise	16.31	12,931	210,905	44,353	May 13 04:41 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 10 '24	Sale	74.14	12,931	958,717	31,422	May 13 04:41 PM
Dockendorff Charles J	Director	May 07 '24	Sale	72.70	3,946	286,874	0	May 08 04:11 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '24	Option Exercise	0.00	4,203	0	54,841	May 06 04:18 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '24	Option Exercise	0.00	2,102	0	31,039	May 06 04:17 PM
Sorenson John Bradley	EVP, Global Operations	May 01 '24	Option Exercise	17.26	17,587	303,552	68,225	May 02 04:46 PM
Sorenson John Bradley	EVP, Global Operations	May 01 '24	Sale	71.50	17,587	1,257,488	50,638	May 02 04:46 PM
Carruthers Wendy	EVP, Human Resources	May 01 '24	Option Exercise	19.31	4,263	82,306	55,331	May 02 04:42 PM
Carruthers Wendy	EVP, Human Resources	May 01 '24	Sale	71.47	6,983	499,075	48,348	May 02 04:42 PM
LUDWIG EDWARD J	Director	Apr 26 '24	Option Exercise	17.37	9,818	170,539	51,192	Apr 29 04:12 PM
LUDWIG EDWARD J	Director	Apr 26 '24	Sale	73.29	9,818	719,562	41,374	Apr 29 04:12 PM
Sorenson John Bradley	EVP, Global Operations	Apr 01 '24	Option Exercise	16.31	16,351	266,685	66,989	Apr 02 06:57 PM
Sorenson John Bradley	EVP, Global Operations	Apr 01 '24	Sale	69.30	16,351	1,133,069	50,638	Apr 02 06:57 PM
Carruthers Wendy	EVP, Human Resources	Apr 01 '24	Option Exercise	19.31	4,263	82,306	58,051	Apr 02 06:57 PM
Carruthers Wendy	EVP, Human Resources	Apr 01 '24	Sale	68.42	6,983	477,777	51,068	Apr 02 06:57 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Mar 18 '24	Sale	66.45	14,506	963,930	58,098	Mar 19 04:41 PM
Carruthers Wendy	EVP, Human Resources	Mar 01 '24	Option Exercise	19.31	4,263	82,306	60,771	Mar 04 06:50 PM
Carruthers Wendy	EVP, Human Resources	Mar 01 '24	Sale	66.35	6,983	463,322	53,788	Mar 04 06:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 26 '24	Option Exercise	21.40	4,185	89,542	38,272	Feb 27 04:19 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 26 '24	Sale	67.07	9,335	626,098	28,937	Feb 27 04:19 PM
Carruthers Wendy	EVP, Human Resources	Feb 23 '24	Option Exercise	19.31	4,263	82,306	63,491	Feb 26 04:13 PM
Carruthers Wendy	EVP, Human Resources	Feb 23 '24	Sale	66.89	6,983	467,093	56,508	Feb 26 04:13 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 21 '24	Sale	66.35	4,960	329,096	72,604	Feb 22 04:19 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 18 '24	Option Exercise	0.00	2,002	0	31,204	Feb 20 09:05 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 17 '24	Option Exercise	0.00	2,500	0	30,650	Feb 20 09:05 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 16 '24	Option Exercise	0.00	2,263	0	29,461	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '24	Option Exercise	0.00	1,186	0	51,179	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '24	Option Exercise	0.00	1,500	0	50,678	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '24	Option Exercise	0.00	1,273	0	49,759	Feb 20 09:05 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 18 '24	Option Exercise	0.00	638	0	38,240	Feb 20 09:04 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 17 '24	Option Exercise	0.00	1,000	0	38,006	Feb 20 09:04 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 16 '24	Option Exercise	0.00	990	0	37,433	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 18 '24	Option Exercise	0.00	2,817	0	78,849	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '24	Option Exercise	0.00	3,333	0	77,552	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '24	Option Exercise	0.00	2,970	0	75,574	Feb 20 09:04 PM
Carruthers Wendy	EVP, Human Resources	Feb 18 '24	Option Exercise	0.00	1,853	0	63,100	Feb 20 09:03 PM
Carruthers Wendy	EVP, Human Resources	Feb 17 '24	Option Exercise	0.00	2,250	0	62,245	Feb 20 09:03 PM
Carruthers Wendy	EVP, Human Resources	Feb 16 '24	Option Exercise	0.00	2,051	0	60,905	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 18 '24	Option Exercise	0.00	16,307	0	1,681,111	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '24	Option Exercise	0.00	18,333	0	1,672,935	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '24	Option Exercise	0.00	16,265	0	1,661,816	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 18 '24	Option Exercise	0.00	2,372	0	35,139	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '24	Option Exercise	0.00	2,833	0	34,024	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '24	Option Exercise	0.00	2,546	0	32,321	Feb 20 09:03 PM
Brennan Daniel J.	EVP and CFO	Feb 20 '24	Option Exercise	13.08	13,662	178,699	285,204	Feb 20 09:03 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '24	Option Exercise	0.00	3,706	0	273,186	Feb 20 09:03 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '24	Option Exercise	0.00	4,583	0	271,513	Feb 20 09:03 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '24	Option Exercise	0.00	4,243	0	268,812	Feb 20 09:03 PM
Brennan Daniel J.	EVP and CFO	Feb 20 '24	Sale	65.86	13,662	899,779	271,542	Feb 20 09:03 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 18 '24	Option Exercise	0.00	3,706	0	194,696	Feb 20 09:03 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '24	Option Exercise	0.00	4,167	0	193,047	Feb 20 09:03 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '24	Option Exercise	0.00	3,960	0	190,686	Feb 20 09:03 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 18 '24	Option Exercise	0.00	741	0	32,544	Feb 20 09:03 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '24	Option Exercise	0.00	1,000	0	32,097	Feb 20 09:03 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '24	Option Exercise	0.00	1,838	0	31,637	Feb 20 09:03 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 14 '24	Option Exercise	0.00	2,379	0	28,576	Feb 16 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '24	Option Exercise	0.00	2,115	0	49,451	Feb 16 04:23 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 14 '24	Option Exercise	0.00	1,057	0	36,931	Feb 16 04:22 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '24	Option Exercise	0.00	2,776	0	73,870	Feb 16 04:22 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '24	Option Exercise	0.00	16,523	0	1,652,879	Feb 16 04:22 PM
Carruthers Wendy	EVP, Human Resources	Feb 14 '24	Option Exercise	0.00	2,115	0	59,793	Feb 16 04:21 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '24	Option Exercise	0.00	4,362	0	188,716	Feb 16 04:21 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '24	Option Exercise	0.00	3,172	0	31,183	Feb 16 04:21 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '24	Option Exercise	0.00	1,850	0	30,428	Feb 16 04:21 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '24	Option Exercise	0.00	4,362	0	266,504	Feb 16 04:21 PM
LUDWIG EDWARD J	Director	Feb 13 '24	Option Exercise	17.37	7,000	121,590	48,374	Feb 14 04:23 PM
LUDWIG EDWARD J	Director	Feb 13 '24	Sale	65.03	7,000	455,223	41,374	Feb 14 04:23 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jan 12 '24	Sale	60.00	11,660	699,600	173,472	Jan 16 04:39 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 09 '24	Option Exercise	16.31	15,172	247,455	71,760	Jan 10 05:44 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 09 '24	Sale	59.25	15,172	898,941	56,588	Jan 10 05:44 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 04 '24	Option Exercise	16.31	15,000	244,650	71,588	Jan 05 04:53 PM

Open in Screener

HOLX

Hologic, Inc.

Sep 20 • 04:00PM ET

81.39

Dollar change -1.01
Percentage change -1.23	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VO SPY IVV VTV XLV RSP VOE IHI

Index	S&P 500	P/E	27.77	EPS (ttm)	2.93	Insider Own	1.39%	Shs Outstand	241.71M	Perf Week	0.30%
Market Cap	18.90B	Forward P/E	18.46	EPS next Y	4.41	Insider Trans	-3.44%	Shs Float	229.04M	Perf Month	1.71%
Income	701.50M	PEG	3.61	EPS next Q	1.01	Inst Own	98.80%	Short Float	2.45%	Perf Quarter	11.39%
Sales	3.99B	P/S	4.74	EPS this Y	3.13%	Inst Trans	-9.78%	Short Ratio	3.63	Perf Half Y	7.77%
Book/sh	21.33	P/B	3.81	EPS next Y	7.97%	ROA	7.70%	Short Interest	5.61M	Perf Year	13.91%
Cash/sh	10.50	P/C	7.75	EPS next 5Y	7.70%	ROE	13.85%	52W Range	64.02 - 84.67	Perf YTD	13.91%
Dividend Est.	-	P/FCF	18.45	EPS past 5Y	-	ROI	9.39%	52W High	-3.87%	Beta	0.98
Dividend TTM	-	Quick Ratio	3.32	Sales past 5Y	7.03%	Gross Margin	54.65%	52W Low	27.13%	ATR (14)	1.38
Dividend Ex-Date	-	Current Ratio	3.99	EPS Y/Y TTM	51.38%	Oper. Margin	23.14%	RSI (14)	51.15	Volatility	1.51% 1.45%
Employees	6990	Debt/Eq	0.52	Sales Y/Y TTM	-1.26%	Profit Margin	17.59%	Recom	2.05	Target Price	88.80
Option/Short	Yes / Yes	LT Debt/Eq	0.51	EPS Q/Q	601.52%	Payout	0.00%	Rel Volume	1.64	Prev Close	82.40
Sales Surprise	0.96%	EPS Surprise	4.19%	Sales Q/Q	2.74%	Earnings	Jul 29 AMC	Avg Volume	1.54M	Price	81.39
SMA20	0.26%	SMA50	0.92%	SMA200	7.44%	Trades		Volume	2,533,498	Change	-1.23%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75
Jul-18-22	Downgrade	BTIG Research	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$75
Apr-04-22	Downgrade	Evercore ISI	Outperform → In-line	$80
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$85 → $78
Oct-15-21	Resumed	Cowen	Outperform	$83
Oct-14-21	Initiated	Redburn	Neutral
Jul-06-21	Upgrade	Evercore ISI	In-line → Outperform	$78
Nov-20-20	Downgrade	Needham	Buy → Hold
Nov-05-20	Reiterated	Needham	Buy	$78 → $88
Jun-30-20	Upgrade	Cowen	Market Perform → Outperform	$64
Jun-03-20	Upgrade	Raymond James	Mkt Perform → Outperform	$62
Apr-30-20	Upgrade	SVB Leerink	Mkt Perform → Outperform	$62
Apr-30-20	Reiterated	Needham	Buy	$52 → $60

Show Previous Ratings

Sep-17-24 09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Sep-11-24 09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-06-24 09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Sep-02-24 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Aug-29-24 08:08AM	Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
11:30AM	Loading…
Aug-28-24 11:30AM	Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report? (Zacks)
Aug-26-24 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Aug-20-24 08:01AM	Should You Hold Hologic (HOLX) Stock in Your Portfolio Now? (Zacks)
Aug-13-24 09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
Aug-09-24 08:20AM	Hologic (HOLX) Q3 Results Review: How to Play the Stock Now? (Zacks)
06:51AM	Hologic, Inc. (HOLX): Are Street Analysts Bullish on This Cosmetic Surgery and Aesthetics Stock Now? (Insider Monkey)
Aug-05-24 09:15AM	Hologic (HOLX) International Revenue in Focus: Trends and Expectations (Zacks)
Aug-02-24 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Aug-01-24 04:40PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Jul-31-24 09:30AM	Brokers Suggest Investing in Hologic (HOLX): Read This Before Placing a Bet (Zacks)
01:04PM	Loading…
Jul-30-24 01:04PM	Hologic CEO on earnings beat: our Covid work has 'turbocharged' diagnostics business (CNBC TV)
11:20AM	Q3 2024 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
08:22AM	Analyst Report: Hologic, Inc. (Morningstar Research)
08:08AM	Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise (Zacks)
04:32AM	Hologic posts 2.7% increase in revenue for Q3 2024 (Medical Device Network)
Jul-29-24 07:22PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:30PM	Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Hologic (HOLX) Q3 Earnings and Revenues Top Estimates (Zacks)
04:10PM	Hologic: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Third Quarter of Fiscal 2024 (Business Wire)
Jul-26-24 11:52AM	Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions (Zacks)
05:12AM	Hologic acquires UKs Endomagnetics for $310m (Medical Device Network)
Jul-25-24 09:15AM	Gear Up for Hologic (HOLX) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
08:19AM	Hologic Completes Acquisition of Endomagnetics Ltd (Business Wire)
Jul-22-24 05:45PM	Hologic (HOLX) Advances But Underperforms Market: Key Facts (Zacks)
08:55AM	Loading…
Jul-19-24 08:55AM	Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings (Zacks)
Jul-17-24 09:10AM	Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have? (Zacks)
Jul-16-24 05:45PM	Hologic (HOLX) Exceeds Market Returns: Some Facts to Consider (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-09-24 04:05AM	72 Million American Women Have Skipped or Delayed Vital Screenings (Business Wire)
Jul-08-24 05:45PM	Hologic (HOLX) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-04-24 08:35AM	Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying? (Zacks)
Jul-02-24 08:22AM	Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024 (Business Wire)
Jun-27-24 10:25AM	3 Online Sports Betting Stocks That Look Like Likely Winners (InvestorPlace)
Jun-25-24 05:45PM	Hologic (HOLX) Stock Sinks As Market Gains: Here's Why (Zacks)
09:30AM	Wall Street Bulls Look Optimistic About Hologic (HOLX): Should You Buy? (Zacks)
Jun-24-24 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Jun-11-24 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-04-24 12:08PM	Hologic CEO breaks down AI involvement in healthcare (CNBC TV)
May-31-24 09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-29-24 09:30AM	Wall Street Analysts Think Hologic (HOLX) Is a Good Investment: Is It? (Zacks)
May-23-24 08:53AM	FDA classifies Hologics recall of BioZorb Marker as Class I (Medical Device Network)
06:00AM	Hologic recalls more than 53,000 radiographic markers linked to 71 injuries (MedTech Dive)
May-21-24 08:08AM	Hologic to Webcast Presentations at Upcoming Investor Conferences (Business Wire)
May-20-24 09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
May-13-24 09:30AM	Hologic (HOLX) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
May-09-24 08:21AM	Argus Adjusts Price Target on Hologic to $95 From $89 (MT Newswires)
May-07-24 11:12AM	A Dive into Hologic (HOLX) International Revenue Trends and Forecasts (Zacks)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
May-04-24 01:07AM	Decoding Hologic Inc (HOLX): A Strategic SWOT Insight (GuruFocus.com)
May-03-24 12:40PM	Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript (Insider Monkey)
12:29PM	Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up (Zacks)
11:54AM	JPMorgan Adjusts Price Target on Hologic to $91 From $85 (MT Newswires)
10:51AM	UBS Adjusts Price Target on Hologic to $81 From $79, Maintains Neutral Rating (MT Newswires)
09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:17AM	Q2 2024 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 09:59PM	Analyst Report: Hologic, Inc. (Morningstar Research)
08:58PM	HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
08:00PM	Hologic (HOLX) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Hologic Inc. (HOLX) Surpasses Q2 Fiscal 2024 Earnings and Revenue Estimates (GuruFocus.com)
05:10PM	Hologic (HOLX) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:40PM	Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours (MT Newswires)
04:07PM	Hologic: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Second Quarter of Fiscal 2024 (Business Wire)
Apr-30-24 06:27AM	Hologic to buy Endomagnetics for $310M (MedTech Dive)
Apr-29-24 05:58PM	Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million (MT Newswires)
04:05PM	Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company (Business Wire)
11:44AM	How You Should Play Hologic (HOLX) Ahead of Q2 Earnings (Zacks)
09:16AM	Stay Ahead of the Game With Hologic (HOLX) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Apr-25-24 10:01AM	Hologic (HOLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-22-24 05:45PM	Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Apr-21-24 08:30AM	This CEO has battled billionaire activist Carl Icahn twice here's his advice to Disney CEO Bob Iger (Yahoo Finance)
Apr-19-24 11:30AM	Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-17-24 11:01AM	Hologic (HOLX) to Report Q2 Earnings: What's in the Cards? (Zacks)
Apr-15-24 05:45PM	Hologic (HOLX) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Apr-12-24 10:45AM	Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail (Zacks)
Apr-11-24 02:07PM	Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography (Business Wire)
09:15AM	Biotech Innovations Paving the Way in Breast Cancer Fight (PR Newswire)
Apr-08-24 05:45PM	Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-03-24 12:10PM	Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:54AM	UPS upgraded, PepsiCo downgraded: Wall Street's top analyst calls (The Fly)
Apr-02-24 05:45PM	Hologic (HOLX) Stock Moves -0.05%: What You Should Know (Zacks)
08:08AM	Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024 (Business Wire)
Mar-28-24 07:24AM	Hologic expects facility closures in diagnostics division (MedTech Dive)
Mar-27-24 09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Mar-25-24 05:45PM	Hologic (HOLX) Ascends While Market Falls: Some Facts to Note (Zacks)
Mar-19-24 12:53PM	Deeming Mass Layoffs a Failure of Leadership, One Company Fine-Tunes a Strategy to Avoid Them (The Wall Street Journal)
Mar-18-24 05:45PM	Hologic (HOLX) Rises But Trails Market: What Investors Should Know (Zacks)
Mar-15-24 07:00PM	Director Scott Garrett Sells 16,441 Shares of Hologic Inc (HOLX) (GuruFocus.com)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Mar-12-24 05:45PM	Hologic (HOLX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Mar-06-24 11:15AM	Hologic's (HOLX) BCI Genomic Test Study Outcome Favorable (Zacks)
Mar-05-24 08:10AM	Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing (Business Wire)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Option Exercise	40.95	32,805	1,343,214	136,721	Sep 03 04:15 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Sale	80.56	52,679	4,243,662	84,042	Sep 03 04:15 PM
Oberton Karleen Marie	Officer	Aug 29 '24	Proposed Sale	80.56	52,679	4,243,657		Aug 29 04:36 PM
Schnittker Brandon	Div. President, GYN Surgical	Aug 06 '24	Sale	83.11	476	39,559	3,735	Aug 08 04:08 PM
Schnittker Brandon	Officer	Aug 06 '24	Proposed Sale	83.11	476	39,559		Aug 06 04:48 PM
COHN BENJAMIN JORDAN	Principal Accounting Officer	Aug 01 '24	Sale	81.99	5,093	417,570	10,476	Aug 05 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Option Exercise	26.21	44,039	1,154,262	1,201,601	Aug 01 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Sale	81.70	44,039	3,597,924	1,157,562	Aug 01 04:09 PM
COHN BENJAMIN JORDAN	Officer	Aug 01 '24	Proposed Sale	81.99	5,093	417,574		Aug 01 03:58 PM
MACMILLAN STEPHEN P	Officer	Jul 30 '24	Proposed Sale	81.70	44,039	3,597,894		Jul 30 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Option Exercise	26.21	3,672	96,243	1,161,234	Jul 19 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Sale	80.13	3,672	294,223	1,157,562	Jul 19 04:09 PM
Stamoulis Christiana	Director	Jul 17 '24	Option Exercise	26.74	9,039	241,703	54,511	Jul 19 04:06 PM
Stamoulis Christiana	Director	Jul 17 '24	Sale	79.50	9,039	718,600	45,472	Jul 19 04:06 PM
GARRETT SCOTT T	Director	Mar 14 '24	Option Exercise	30.93	16,441	508,471	65,052	Mar 15 04:11 PM
GARRETT SCOTT T	Director	Mar 14 '24	Sale	75.50	16,441	1,241,296	48,611	Mar 15 04:11 PM
Dockendorff Charles J	Director	Mar 08 '24	Sale	76.21	1,465	111,648	1,572	Mar 11 06:45 PM
CRAWFORD SALLY	Director	Mar 08 '24	Option Exercise	26.74	9,039	241,703	141,966	Mar 11 06:41 PM
CRAWFORD SALLY	Director	Mar 08 '24	Sale	76.40	9,039	690,607	132,927	Mar 11 06:41 PM
Oberton Karleen Marie	Chief Financial Officer	Jan 29 '24	Sale	75.00	14,940	1,120,500	103,916	Jan 30 04:08 PM
Dockendorff Charles J	Director	Jan 02 '24	Option Exercise	38.44	7,551	290,260	17,482	Jan 04 04:09 PM
Dockendorff Charles J	Director	Jan 02 '24	Sale	72.00	16,017	1,153,224	1,465	Jan 04 04:09 PM
GARRETT SCOTT T	Director	Dec 11 '23	Sale	68.71	10,000	687,116	47,039	Dec 13 04:07 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Nov 29 '23	Option Exercise	26.21	47,711	1,250,505	1,286,799	Dec 01 04:04 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Nov 29 '23	Sale	70.41	47,711	3,359,188	1,239,088	Dec 01 04:04 PM
Mitchell Essex D	Div. President, GYN Surgical	Nov 21 '23	Sale	71.85	7,500	538,890	12,827	Nov 24 04:02 PM

Open in Screener

HAE

Haemonetics Corp.

Sep 20 • 04:00PM ET

74.83

Dollar change -0.25
Percentage change -0.33	%

Healthcare • Medical Instruments & Supplies • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IJH IWM VB VXF VBK IWO MDY SCHA VTWO

Index	RUT	P/E	33.52	EPS (ttm)	2.23	Insider Own	1.10%	Shs Outstand	50.79M	Perf Week	-1.66%
Market Cap	3.83B	Forward P/E	13.82	EPS next Y	5.41	Insider Trans	-6.38%	Shs Float	50.61M	Perf Month	-0.77%
Income	114.89M	PEG	2.39	EPS next Q	1.07	Inst Own	109.83%	Short Float	12.04%	Perf Quarter	-12.16%
Sales	1.33B	P/S	2.87	EPS this Y	16.11%	Inst Trans	-0.55%	Short Ratio	10.28	Perf Half Y	-6.80%
Book/sh	17.70	P/B	4.23	EPS next Y	17.73%	ROA	5.10%	Short Interest	6.09M	Perf Year	-18.49%
Cash/sh	6.73	P/C	11.12	EPS next 5Y	14.00%	ROE	12.98%	52W Range	70.74 - 97.97	Perf YTD	-12.49%
Dividend Est.	1.00 (1.34%)	P/FCF	52.50	EPS past 5Y	17.09%	ROI	5.41%	52W High	-23.62%	Beta	0.30
Dividend TTM	-	Quick Ratio	2.33	Sales past 5Y	6.80%	Gross Margin	50.96%	52W Low	5.78%	ATR (14)	2.12
Dividend Ex-Date	-	Current Ratio	3.76	EPS Y/Y TTM	-16.22%	Oper. Margin	14.65%	RSI (14)	43.61	Volatility	2.80% 2.31%
Employees	3657	Debt/Eq	1.35	Sales Y/Y TTM	9.47%	Profit Margin	8.61%	Recom	1.73	Target Price	109.80
Option/Short	Yes / Yes	LT Debt/Eq	1.35	EPS Q/Q	-6.91%	Payout	0.00%	Rel Volume	1.74	Prev Close	75.08
Sales Surprise	0.33%	EPS Surprise	1.44%	Sales Q/Q	7.98%	Earnings	Aug 08 BMO	Avg Volume	592.44K	Price	74.83
SMA20	-0.31%	SMA50	-7.39%	SMA200	-9.82%	Trades		Volume	1,031,398	Change	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-13-24	Initiated	CL King	Buy	$116
Sep-11-24	Initiated	BofA Securities	Neutral	$85
Sep-10-24	Initiated	BTIG Research	Buy	$112
Jun-12-24	Upgrade	Needham	Hold → Buy	$112
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform	$140
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$106
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy	$138
Aug-07-19	Reiterated	Barrington Research	Outperform	$116 → $139
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform	$110

Show Previous Ratings

Today 12:54AM	Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 (Insider Monkey)
Sep-02-24 09:35AM	After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE) (Zacks)
Aug-23-24 09:22AM	Implied Volatility Surging for Haemonetics (HAE) Stock Options (Zacks)
Aug-16-24 09:08AM	Haemonetics (HAE) Set to Launch VASCADE MVP XL in US (Zacks)
06:33AM	Haemonetics Vascade MVP XL vascular closure system enters US market (Medical Device Network)
06:30AM	Loading…
Aug-15-24 06:30AM	Haemonetics Announces Full Market Release for VASCADE MVP XL Vascular Closure System (PR Newswire)
Aug-12-24 07:47AM	Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises (Zacks)
Aug-09-24 09:40AM	Is Haemonetics (HAE) Stock Undervalued Right Now? (Zacks)
09:35AM	Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 07:25AM	Haemonetics (HAE) Misses Q1 Earnings Estimates (Zacks) -10.84%
06:25AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-07-24 09:55AM	Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Aug-01-24 07:00AM	Sotera Health Appoints Christopher Simon to the Board of Directors (GlobeNewswire)
06:00AM	Loading…
Jul-30-24 06:00AM	Haemonetics Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire (PR Newswire)
Jul-29-24 10:20AM	Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings (Zacks)
Jul-16-24 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Jul-12-24 11:38AM	Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches (Zacks)
Jul-10-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet (Zacks)
Jul-08-24 04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 (PR Newswire)
Jun-27-24 09:35AM	Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jun-19-24 01:26PM	Haemonetics (HAE) Expands VASCADE Line With New Limited Launch (Zacks)
04:52AM	Haemonetics launches VASCADE MVP XL device for venous closure (Medical Device Network)
Jun-18-24 04:15PM	Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device (PR Newswire)
Jun-14-24 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jun-13-24 10:19AM	Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation (Zacks)
Jun-03-24 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
May-30-24 02:41AM	Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares (GuruFocus.com)
02:41AM	Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE) (GuruFocus.com)
09:40AM	Loading…
May-29-24 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
May-27-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE) (Zacks)
May-24-24 09:55AM	Wall Street Analysts Believe Haemonetics (HAE) Could Rally 26.58%: Here's is How to Trade (Zacks)
May-23-24 12:00PM	Haemonetics (HAE) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
06:00AM	Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes (PR Newswire)
May-22-24 09:13AM	Here's Why You Should Buy Haemonetics (HAE) Stock Now (Zacks)
02:06AM	Insider Sale: EVP Josep Llorens Sells Shares of Haemonetics Corp (HAE) (GuruFocus.com)
May-21-24 04:05PM	Haemonetics Announces Proposed Convertible Senior Notes Offering (PR Newswire)
May-17-24 12:00PM	Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid (Zacks)
10:20AM	Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue? (Zacks)
May-14-24 09:15AM	Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-13-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
May-10-24 03:57PM	Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript (Insider Monkey)
12:41PM	Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ... (GuruFocus.com)
10:53AM	Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand (Zacks)
10:37AM	Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating (MT Newswires)
May-09-24 10:55AM	HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
09:30AM	Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates (Zacks)
06:39AM	Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise (MT Newswires)
06:28AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
May-08-24 09:15PM	Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ... (GuruFocus.com)
May-06-24 09:16AM	Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS (Zacks)
May-01-24 11:51AM	Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs (Zacks)
Apr-12-24 09:03AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Apr-10-24 04:58PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 (PR Newswire)
Apr-08-24 03:20PM	Royce Investment Partners Commentary: What Will Fuel Small-Cap Returns? (GuruFocus.com)
Apr-05-24 09:48AM	Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval (Zacks)
Apr-04-24 06:30AM	Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge (PR Newswire)
Apr-01-24 08:00AM	Haemonetics Corporation Completes Acquisition of Attune Medical (PR Newswire)
Mar-29-24 09:30AM	Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Mar-11-24 09:30AM	Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Mar-06-24 06:54AM	Haemonetics (HAE) Signs Agreement to Acquire Attune Medical (Zacks)
Mar-05-24 06:18AM	Haemonetics to buy Attune Medical for $160M (MedTech Dive)
06:00AM	Haemonetics Announces Definitive Agreement to Acquire Attune Medical (PR Newswire)
Feb-27-24 12:00PM	What Makes Haemonetics (HAE) a New Buy Stock (Zacks)
Feb-21-24 05:57PM	Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference (PR Newswire)
05:55PM	Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day (PR Newswire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-09-24 10:39AM	Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised (Zacks) -5.01%
10:34AM	Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript (Insider Monkey)
09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Feb-08-24 10:00PM	Q3 2024 Haemonetics Corp Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:10AM	Haemonetics (HAE) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
06:33AM	Haemonetics Corp (HAE) Reports Revenue Growth and Updates Fiscal 2024 Guidance (GuruFocus.com)
06:10AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
Feb-05-24 09:16AM	Haemonetics (HAE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Feb-01-24 10:00AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-31-24 12:45PM	Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
Jan-18-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-12-24 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Jan-11-24 04:05PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 (PR Newswire)
Jan-03-24 01:56PM	Haemonetics (HAE) Up 11% in a Year: Will the Rally Continue? (Zacks)
Dec-29-23 12:34PM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Dec-25-23 09:30AM	Haemonetics (HAE) Just Reclaimed the 200-Day Moving Average (Zacks)
09:30AM	Haemonetics (HAE) Just Overtook the 50-Day Moving Average (Zacks)
Dec-18-23 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
Dec-15-23 12:45PM	Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Dec-12-23 06:00AM	Haemonetics Corporation Completes Acquisition of OpSens Inc. (PR Newswire)
Dec-07-23 04:05PM	Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-05-23 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Dec-04-23 12:09PM	Here's Why You Should Invest in Haemonetics (HAE) Right Now (Zacks)
Nov-30-23 09:35AM	Haemonetics (HAE) Loses -6.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-28-23 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE) (Zacks)
Nov-27-23 12:39PM	Haemonetics (HAE) Stock Up 4.2% YTD: Will the Rally Continue? (Zacks)
10:46AM	Haemonetics' (HAE) Plasma Growth, Innovation Aid Performance (Zacks)
Nov-23-23 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Strong Stewart W	President, Global Hospital	Jul 26 '24	Sale	91.15	4,312	393,039	18,196	Jul 29 05:03 PM
Strong Stewart W	Officer	Jul 26 '24	Proposed Sale	91.15	4,312	393,039		Jul 26 09:47 AM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 11 '24	Sale	90.00	2,136	192,240	21,410	Jul 15 04:27 PM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 12 '24	Sale	90.00	79	7,110	21,331	Jul 15 04:27 PM
Simon, Christopher	President & CEO	Jun 06 '24	Option Exercise	41.64	104,516	4,352,046	433,877	Jun 07 04:15 PM
Basil Michelle L	EVP and General Counsel	May 29 '24	Sale	88.08	12,990	1,144,208	31,257	May 29 05:38 PM
Strong Stewart W	President, Global Hospital	May 29 '24	Sale	87.53	8,857	775,253	18,196	May 29 05:27 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Option Exercise	56.57	2,241	126,773	20,437	May 21 06:01 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Sale	95.11	686	65,245	18,196	May 21 06:01 PM
Llorens Josep	EVP, Global Manufacturing	May 20 '24	Sale	95.08	987	93,844	21,310	May 21 05:52 PM
Llorens Josep	EVP, Global Manufacturing	May 17 '24	Sale	94.82	822	77,942	16,350	May 21 05:52 PM
Basil Michelle L	EVP and General Counsel	May 20 '24	Sale	95.08	1,604	152,508	31,257	May 21 05:46 PM
Basil Michelle L	EVP and General Counsel	May 17 '24	Sale	95.00	1,073	101,935	29,352	May 21 05:46 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Option Exercise	57.60	2,410	138,816	18,018	May 17 05:11 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Sale	96.04	733	70,397	15,608	May 17 05:11 PM
Basil Michelle L	EVP and General Counsel	May 16 '24	Sale	96.14	985	94,698	30,425	May 17 05:02 PM
Llorens Josep	EVP, Global Manufacturing	May 16 '24	Sale	96.14	770	74,028	17,172	May 17 04:55 PM
Lingamneni Anila	EVP, Chief Technology Officer	May 06 '24	Sale	95.00	2,305	218,975	12,295	May 08 04:21 PM

Open in Screener

KEYS

Keysight Technologies Inc

Sep 20 • 04:00PM ET

152.42

Dollar change -2.96
Percentage change -1.91	%

Technology • Scientific & Technical Instruments • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

KEYS Keysight Technologies Inc daily Stock Chart

Held by: VTI VOO VO SPY IVV MOAT VTV VGT XLK VOE

Index	S&P 500	P/E	29.33	EPS (ttm)	5.20	Insider Own	0.79%	Shs Outstand	174.60M	Perf Week	1.59%
Market Cap	26.45B	Forward P/E	21.83	EPS next Y	6.98	Insider Trans	-0.43%	Shs Float	172.17M	Perf Month	-3.42%
Income	913.00M	PEG	-	EPS next Q	1.57	Inst Own	89.29%	Short Float	1.25%	Perf Quarter	11.26%
Sales	5.00B	P/S	5.29	EPS this Y	-25.81%	Inst Trans	-3.18%	Short Ratio	1.75	Perf Half Y	-1.18%
Book/sh	30.14	P/B	5.06	EPS next Y	12.99%	ROA	10.06%	Short Interest	2.16M	Perf Year	15.00%
Cash/sh	9.40	P/C	16.21	EPS next 5Y	-2.04%	ROE	18.03%	52W Range	118.57 - 162.51	Perf YTD	-4.19%
Dividend Est.	-	P/FCF	28.85	EPS past 5Y	46.88%	ROI	13.79%	52W High	-6.21%	Beta	0.97
Dividend TTM	-	Quick Ratio	1.39	Sales past 5Y	7.32%	Gross Margin	63.26%	52W Low	28.55%	ATR (14)	3.79
Dividend Ex-Date	-	Current Ratio	2.03	EPS Y/Y TTM	-17.55%	Oper. Margin	18.91%	RSI (14)	59.13	Volatility	1.80% 2.09%
Employees	14900	Debt/Eq	0.39	Sales Y/Y TTM	-10.60%	Profit Margin	18.25%	Recom	1.93	Target Price	169.73
Option/Short	Yes / Yes	LT Debt/Eq	0.27	EPS Q/Q	38.16%	Payout	0.00%	Rel Volume	1.46	Prev Close	155.38
Sales Surprise	1.92%	EPS Surprise	16.37%	Sales Q/Q	-11.94%	Earnings	Aug 20 AMC	Avg Volume	1.24M	Price	152.42
SMA20	1.27%	SMA50	7.84%	SMA200	3.30%	Trades		Volume	1,806,406	Change	-1.91%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-24	Initiated	Vertical Research	Buy	$175
Feb-15-24	Downgrade	JP Morgan	Overweight → Neutral	$184 → $170
Sep-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$165
Sep-05-23	Upgrade	Goldman	Neutral → Buy	$146 → $164
Aug-18-23	Downgrade	Barclays	Overweight → Equal Weight	$204 → $144
Aug-14-23	Downgrade	BofA Securities	Neutral → Underperform	$163 → $148
Jun-30-23	Initiated	Citigroup	Buy	$200
Jan-11-23	Downgrade	Goldman	Buy → Neutral	$196 → $189
Jan-10-23	Upgrade	Barclays	Equal Weight → Overweight	$175 → $202
Nov-03-22	Initiated	Wells Fargo	Overweight	$200
Mar-11-22	Upgrade	Deutsche Bank	Hold → Buy	$176
Dec-08-21	Initiated	Morgan Stanley	Equal-Weight	$200
Nov-23-21	Reiterated	Jefferies	Buy	$190 → $220
Nov-23-21	Reiterated	Credit Suisse	Outperform	$175 → $210
Nov-23-21	Reiterated	Citigroup	Buy	$190 → $220
Jul-02-21	Downgrade	Barclays	Overweight → Equal Weight	$162
Jan-25-21	Downgrade	Deutsche Bank	Buy → Hold	$150
Nov-16-20	Initiated	Deutsche Bank	Buy	$129
Sep-16-20	Initiated	UBS	Buy	$133
Aug-13-20	Upgrade	Goldman	Neutral → Buy	$120

Show Previous Ratings

Today 04:51AM	Viavi considers reviving rival bid for Spirent, say sources (Reuters)
Sep-19-24 04:05PM	Synopsys Enters Definitive Agreement with Keysight Technologies For Sale of Optical Solutions Group (PR Newswire)
04:05PM	Keysight Advances Software-Centric Solutions Strategy with Planned Acquisition of Synopsys Optical Solutions Group (Business Wire)
11:30AM	Keysight (KEYS) Down 4.8% Since Last Earnings Report: Can It Rebound? (Zacks)
11:00AM	Keysight Advances Capabilities of Vector Network Analyzer Portfolio (Business Wire)
11:00AM	Loading…
Sep-18-24 11:00AM	Keysight Unveils Optical Reference Transmitter to Validate Next-Generation Data Transmission (Business Wire)
Sep-17-24 01:45PM	Keysight Technologies, Inc. (NYSE:KEYS): A Chip Stock Powering The AI Boom (Insider Monkey)
11:00AM	Keysight Introduces Quantum Circuit Simulation the First Circuit Environment with Frequency-Domain Flux Quantization (Business Wire)
09:00AM	Frost & Sullivan Recognizes Keysight's Network Packet Brokers with 2024 New Product Innovation Award (PR Newswire)
Sep-13-24 11:00AM	Keysight and Autotalks Advance Vehicle-to-Everything Automotive Security with Standard-Influencing Security Evaluation (Business Wire)
Sep-12-24 11:00AM	Keysight to Demonstrate New Solutions that Accelerate Next Generation AI Infrastructure at ECOC 2024 (Business Wire)
Sep-11-24 11:00AM	Keysight to Spotlight Solutions That Accelerate Radio Frequency Innovations at European Microwave Week 2024 (Business Wire)
Sep-04-24 11:00AM	Keysight Introduces Advanced 14-bit Precision Oscilloscope for General Applications (Business Wire)
03:35AM	Winners And Losers Of Q2: FARO (NASDAQ:FARO) Vs The Rest Of The Inspection Instruments Stocks (StockStory)
Sep-02-24 03:45AM	Inspection Instruments Stocks Q2 Teardown: Mirion (NYSE:MIR) Vs The Rest (StockStory)
01:12AM	Loading…
Aug-30-24 01:12AM	Decoding Keysight Technologies Inc (KEYS): A Strategic SWOT Insight (GuruFocus.com)
Aug-28-24 11:00AM	Keysight Unveils Wire Bond Inspection Solution for Semiconductor Manufacturing (Business Wire)
Aug-24-24 12:00PM	3 Stocks to Buy on the Road to AGI (InvestorPlace)
Aug-23-24 07:18AM	Here's Why This Hot Technology Stock Soared This Week (Motley Fool)
Aug-22-24 08:00AM	Keysight to Participate in Upcoming Investor Conferences (Business Wire)
Aug-21-24 06:32PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research) +13.88%
05:26PM	S&P 500 Gains and Losses Today: Target, TJX Shares Soar as Store Traffic Rises (Investopedia)
04:46PM	These Stocks Are Moving the Most Today: Target, Macys, JD.com, Ford, TJX, American Express, BigBear.ai, and More (Barrons.com)
04:31PM	Keysight stock rising on Q3 earnings beat, upbeat guidance (Yahoo Finance Video)
04:16PM	Keysight Technologies Stock Soars as Orders Show Resilience (Investopedia)
03:19PM	Why Keysight Technologies Stock Is Surging Today (Motley Fool)
01:13PM	Keysight (KEYS) Q3 Earnings Beat Estimate Despite Lower Revenues (Zacks)
12:06PM	Midday movers: Target, Toll Brothers, Keysight rise; Macy's, JD.com, La-Z-Boy fall (Investing.com)
09:46AM	Keysight Technologies Stock Has Best Day Since 2020. Earnings Were Encouraging. (Barrons.com)
Aug-20-24 07:01PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research)
05:43PM	Loading…
05:43PM	Keysight Technologies beats third-quarter results estimates on higher orders (Reuters)
05:30PM	Here's What Key Metrics Tell Us About Keysight (KEYS) Q3 Earnings (Zacks)
05:15PM	Keysight (KEYS) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	Keysights (NYSE:KEYS) Q2 Sales Top Estimates, Stock Soars (StockStory)
04:13PM	Keysight: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Keysight Technologies Reports Third Quarter 2024 Results (Business Wire)
Aug-19-24 09:01AM	Earnings To Watch: Keysight Technologies Inc (KEYS) Reports Q3 2024 Result (GuruFocus.com)
03:01AM	Keysight (KEYS) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Aug-15-24 09:15AM	Wall Street's Insights Into Key Metrics Ahead of Keysight (KEYS) Q3 Earnings (Zacks)
Aug-14-24 11:28AM	Will Top-Line Contraction Dent Keysight's (KEYS) Q3 Earnings? (Zacks)
11:00AM	Keysight Joins the Joint Cyber Defense Collaborative to Enhance Cybersecurity for Critical Sectors (Business Wire)
10:27AM	Keysight (KEYS) Achieves First-Ever FR3 5G Data Connection (Zacks)
Aug-13-24 11:00AM	Keysight Establishes First Interoperability and Data Connection in FR3 Frequency Range (Business Wire)
Aug-06-24 11:00AM	Keysight, Ettifos, and Autotalks Make First 3GPP Release 16 Sidelink Radio Interoperability Connection (Business Wire)
Aug-05-24 04:32AM	3 Stocks Down More Than 11% in 2024 That Are Screaming Buys in August (Motley Fool)
Jul-30-24 08:00AM	Keysight Announces Date of Third Quarter 2024 Financial Results Conference Call (Business Wire)
Jul-29-24 11:00AM	Keysight Gains First Validation of 5G New Radio FR1 1024-QAM Demodulation Test Cases (Business Wire)
Jul-24-24 06:27PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research)
11:00AM	Keysight and NXP Set New Standard for Automotive Security with World's First Digital Key Applet (Business Wire)
Jul-23-24 11:00AM	Keysight Named One of the Worlds Most Sustainable Companies in 2024 by TIME Magazine (Business Wire)
Jul-22-24 11:00AM	Keysight and University of Malaga's MobileNet join forces to Accelerate Open RAN Development with RAN Intelligent Controller Testing (Business Wire)
Jul-21-24 06:07AM	Instead of Buying the Dip on EV Stocks Like Tesla and Lucid, Consider These 3 Growth Stocks (Motley Fool)
Jul-18-24 11:00AM	Keysight Introduces PCIe Designer and Chiplet PHY Designer for Digital Standards-Driven Simulation Workflows (Business Wire)
Jul-17-24 01:14PM	Keysight (KEYS) Boosts Simulation Portfolio for Space Application (Zacks)
Jul-16-24 06:34PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research)
11:00AM	Keysight Expands Modular Photovoltaic Emulation Platform with Higher Power Modules (Business Wire)
Jul-15-24 11:00AM	Keysight Honored with Globee Award for Customer Excellence (Business Wire)
Jul-12-24 11:59AM	Keysight (KEYS) Aims to Accelerate AI Deployment in RAN (Zacks)
Jul-11-24 11:00AM	Keysight Joins the AI-RAN Alliance to Advance AI Innovations in Mobile Networks (Business Wire)
Jul-10-24 12:01PM	Keysight (KEYS) Solution to Enhance Vodafone's User Experience (Zacks)
04:51AM	Q1 Earnings Outperformers: Itron (NASDAQ:ITRI) And The Rest Of The Inspection Instruments Stocks (StockStory)
Jul-09-24 12:01PM	Keysight Network Visibility Enhances User Experience of Vodafone's 5G Mobile Network (Business Wire)
Jul-05-24 06:29AM	Inspection Instruments Stocks Q1 Results: Benchmarking Teledyne (NYSE:TDY) (StockStory)
Jul-03-24 05:15AM	Badger Meter (NYSE:BMI) Q1 Earnings: Leading The Inspection Instruments Pack (StockStory)
Jul-02-24 03:45AM	Inspection Instruments Stocks Q1 Recap: Benchmarking Keysight (NYSE:KEYS) (StockStory)
Jul-01-24 09:45AM	Keysight (KEYS) and SGS to Boost Skylo's NTN Certification (Zacks)
Jun-28-24 11:00AM	Keysight Enables SGS to Conduct Testing for Skylo Non-Terrestrial Networks Certification Program (Business Wire)
Jun-27-24 11:00AM	Keysight Technologies Selected as Test Partner by Allion Labs for Thunderbolt 5 Product Certification Testing (Business Wire)
Jun-26-24 11:17AM	Keysight (KEYS) Automates 5G Field Testing Process for Samsung (Zacks)
Jun-25-24 11:00AM	Keysight Streamlines and Automates Samsung Semiconductor India Researchs 5G Field-to-Lab Workflow (Business Wire)
Jun-19-24 11:30AM	Why Is Keysight (KEYS) Down 7% Since Last Earnings Report? (Zacks)
06:30AM	3 Tech Stocks the Market Mispriced (And How You Can Profit Long-Term) (InvestorPlace)
Jun-13-24 11:00AM	Keysight Named by Forbes as one of the Best Employers for Diversity in 2024 (Business Wire)
Jun-11-24 11:00AM	Keysight and SmartViser Enable Testing for EU Energy Efficiency Index Labeling Regulation (Business Wire)
Jun-06-24 11:00AM	Keysight and Ericsson to Demonstrate Pre-6G Network at IEEE International Conference on Communications 2024 (Business Wire)
Jun-04-24 06:29PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research)
11:00AM	Keysight Spotlights Spectrum Innovations at IMS 2024 (Business Wire)
Jun-01-24 01:02AM	Decoding Keysight Technologies Inc (KEYS): A Strategic SWOT Insight (GuruFocus.com)
May-30-24 11:00AM	Keysight Enables Fii to Earn Outdoor Open Radio Unit Certificate of Conformance (Business Wire)
May-28-24 08:00AM	Keysight to Participate in Upcoming Investor Conferences (Business Wire)
May-21-24 04:50PM	S&P 500 Gains and Losses Today: Bright Growth Outlook Lifts First Solar Stock (Investopedia) -8.38%
04:22PM	These Stocks Moved the Most Today: Palo Alto Networks, XPeng, Peloton, First Solar, Keysight, VinFast Auto, Nordson, Lowes, and More (Barrons.com)
03:00PM	These Stocks Are Moving the Most Today: Palo Alto Networks, XPeng, Peloton, First Solar, Keysight, VinFast Auto, Nordson, Lowes, and More (Barrons.com)
01:16PM	Tech Stocks on the Move Today: Palo Alto Networks, Trump Media, and More (Investopedia)
12:58PM	Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024 (Associated Press)
12:41PM	Keysight Shares Decline Following Analyst Actions Post Fiscal Q2 Earnings (MT Newswires)
10:56AM	Keysight Technologies Is the S&P 500s Worst Performer. It Isnt Because of Earnings. (Barrons.com)
10:11AM	Keysight (KEYS) Q2 Earnings Beat Estimate Despite Lower Revenues (Zacks)
08:08AM	Keysight Technologies, Inc. (NYSE:KEYS) Q2 2024 Earnings Call Transcript (Insider Monkey)
07:27AM	Goldman Sachs Adjusts Price Target on Keysight Technologies to $175 From $172 (MT Newswires)
07:17AM	Baird Adjusts Keysight Technologies Price Target to $167 From $155 (MT Newswires)
07:17AM	Susquehanna Adjusts Keysight Technologies Price Target to $195 From $208 (MT Newswires)
06:56AM	Q2 2024 Keysight Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
May-20-24 11:46PM	Analyst Report: Keysight Technologies, Inc. (Morningstar Research)
08:53PM	KEYS Stock Earnings: Keysight Techs Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:00PM	Keysight (KEYS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:21PM	Keysight forecast third-quarter profit below estimates on slow demand (Reuters)
05:15PM	Keysight (KEYS) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:29PM	Keysight Technologies Fiscal Q2 Non-GAAP EPS, Revenue Decrease; Q3 Outlook Issued; Shares Fall After Hours (MT Newswires)
04:17PM	Keysight: Fiscal Q2 Earnings Snapshot (Associated Press Finance)

Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization and secure operation of electronics systems to communications, networking and electronics industries. It operates through the following segments: Communications Solutions Group, and Electronic Industrial Solutions Group. The Communications Solutions Group segment serves customers spanning the worldwide commercial communications end market, which includes internet infrastructure, and the aerospace, defense and government end market. The Electronic Industrial Solutions Group segment offers test and measurement solutions across a broad set of electronic industrial end markets, focusing on high-growth applications in the automotive and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HAMADA RICHARD P	Director	Aug 22 '24	Sale	156.00	1,632	254,592	42,160	Aug 26 07:17 PM
HAMADA RICHARD P	Director	Aug 22 '24	Proposed Sale	156.00	1,632	254,592		Aug 22 02:30 PM
POOLE LISA M.	VP and Controller	Jun 17 '24	Sale	136.45	440	60,038	3,913	Jun 18 07:31 PM
Stephens Kevin A	Director	May 28 '24	Buy	143.35	460	65,941	7,681	May 30 04:28 PM
NARAYANAN KAILASH	SVP	Mar 26 '24	Sale	152.88	4,300	657,384	29,156	Mar 28 04:17 PM
Nersesian Ronald S.	Director	Dec 27 '23	Sale	159.82	29,672	4,742,179	296,619	Dec 28 04:04 PM
NARAYANAN KAILASH	SVP	Dec 15 '23	Sale	159.16	1,006	160,117	33,456	Dec 18 05:36 PM
Dougherty Neil	EVP and CFO	Dec 15 '23	Sale	159.35	14,686	2,340,214	106,793	Dec 18 05:36 PM
Ee Huei Sin	SVP	Dec 14 '23	Sale	156.47	5,000	782,325	44,317	Dec 15 05:45 PM
PAGE JOHN	SVP	Dec 13 '23	Sale	150.00	6,155	923,250	36,767	Dec 15 05:44 PM
Li Jeffrey K	SVP and Secretary	Dec 13 '23	Sale	150.00	4,748	712,200	28,174	Dec 15 05:44 PM
Gooi Soon Chai	SVP	Dec 12 '23	Sale	148.03	14,900	2,205,592	239,488	Dec 13 04:22 PM
CULLEN JAMES	Director	Dec 11 '23	Sale	146.47	4,869	713,154	20,730	Dec 13 04:21 PM
Dhanasekaran Satish	President and CEO	Dec 06 '23	Sale	140.00	11,138	1,559,320	105,139	Dec 08 04:13 PM
Dhanasekaran Satish	President and CEO	Nov 27 '23	Sale	134.90	7,275	981,398	116,277	Nov 29 04:16 PM

BSX

Boston Scientific Corp.

HOLX

Hologic, Inc.

HAE

Haemonetics Corp.

KEYS

Keysight Technologies Inc

Upgrade your FINVIZ experience